Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026)
Neuronetics' (STIM) quarterly Total Non-Current Liabilities came in at $108.3 million in Q1 2026, up 142.92% on a QoQ basis from $44.6 million in Q2 2018.
Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 3 years of Total Non-Current Liabilities data on file, last reported at $108.3 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $108.3 million in Q1 2026; TTM through Mar 2026 was $108.3 million, a N/A change from a year earlier, with the FY2017 full-year figure at $44.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $108.3 million, up from $44.6 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for STIM reached as high as $108.3 million in Q1 2026 and fell as low as $108.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 108.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.31 Mn |
| Jun 30, 2018 | 44.59 Mn |
| Dec 31, 2017 | 43.98 Mn |